Webinar Discusses DNA Damage in Individual Cells
News Sep 30, 2013
AMSBIO has announced a new on-demand webinar entitled 'CometAssay: Detecting single and double strand DNA breaks in individual cells'.
Presented by Dr Sandra Woodgate, a Subject Matter Expert for this technique., this informative webinar explores how the Comet Assay quantitates DNA damage and repair from in vivo and in vitro samples of eukaryotic cells.
The comet assay or single cell gel electrophoresis (SCGE) is a technique to easily and rapidly detect and quantitate DNA fragmentation associated with DNA damage caused by apoptosis and cytotoxicity.
The technique can be particularly useful in the field of genotoxicity testing, human biomonitoring, cellular response to DNA damage, and for screening cancer therapeutics.
In this recorded webinar, Dr Woodgate provides an informative introduction to the Comet Assay, how it works and how standardized CometAssay technology offers a unique system for reproducibly measuring DNA damage.
Further the webinar includes real application data, demonstrating the use of CometAssay techniques for studying cellular response to DNA damage, as well as to screen inhibitors to DNA repair, test chemicals for toxicity and screen samples for environmental mutagens.
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE